HHCepo 50 Dry Syrup contains Cefpodoxime Proxetil 50 mg as its active ingredient, a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity. It is indicated for the treatment of various bacterial infections including respiratory tract infections, otitis media, skin and soft tissue infections, urinary tract infections, and pharyngitis caused by susceptible organisms. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The dry syrup formulation is designed for pediatric use, allowing accurate dosing and improved palatability. After reconstitution, the suspension should be stored as per manufacturer guidelines and used within the recommended period to ensure efficacy. Dosage and duration of therapy should be determined based on the severity of infection, patient age, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, although rare, may occur in patients with a history of penicillin or cephalosporin allergy. It is essential to complete the full prescribed course to prevent the development of resistance. HHCepo 50 Dry Syrup should be used under medical supervision, with caution in patients with renal impairment or history of hypersensitivity to beta-lactam antibiotics.